Treating mental health and substance use disorder patients during the COVID-19 pandemic. Patients who are suffering from a substance use disorder and/or mental health condition are likely to be greatly impacted by the societal changes due to the COVID-19 pandemic. Social distancing may be our best hope to slow the spread of this novel disease.
Screening for substance use in all pregnant women is recommended by both the American College of Obstetrics and Gynecology (ACOG) and the American Society of Addiction Medicine (ASAM) in order to provide women and their fetuses and children with the best care during and after pregnancy.
Women with untreated substance use disorder during pregnancy have multiple and interacting risks that impact both maternal and fetal health. Understanding the complex issues in this group of patients is important for delivering the best care.